Madlen Ulke

IDH1 mutations are detected in 6.6% of 1414 AML patients and are associated with intermediate risk karyotype and unfavorable prognosis in adults younger than 60 years and unmutated NPM1 status

Susanne Schnittger, Claudia Haferlach, Madlen Ulke et al. · Blood · 2010 · 195 citations · Full text

Life Sciences, Genetics, Molecular Genetics +11

WT1 mutations are secondary events in AML, show varying frequencies and impact on prognosis between genetic subgroups

M-T Krauth, Tamara Alpermann, Ulrike Bacher et al. · Leukemia · 2014 · 69 citations

Life Sciences, Genetics, Molecular Genetics +11

Development and validation of a real-time quantification assay to detect and monitor BRAFV600E mutations in hairy cell leukemia

Susanne Schnittger, Ulrike Bacher, Torsten Haferlach et al. · Blood · 2012 · 61 citations · Full text

Medicine, Molecular Genetics, Oncology +10

Use of CBL exon 8 and 9 mutations in diagnosis of myeloproliferative neoplasms and myelodysplastic/myeloproliferative disorders: an analysis of 636 cases

Susanne Schnittger, Ulrike Bacher, Tamara Alpermann et al. · Haematologica · 2012 · 30 citations · Full text

Medicine, Genetics, Molecular Genetics +12